Total Payments
$37,756
2023 Payments
$64.08
Companies
10
Transactions
55
Medicare Patients
3,526
Medicare Billing
$532,388
Payment Breakdown by Category
Consulting$28,845 (76.4%)
Other$4,150 (11.0%)
Travel$3,256 (8.6%)
Food & Beverage$1,308 (3.5%)
Education$196.59 (0.5%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $28,845 | 11 | 76.4% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $4,150 | 2 | 11.0% |
| Travel and Lodging | $3,256 | 16 | 8.6% |
| Food and Beverage | $1,308 | 19 | 3.5% |
| Education | $196.59 | 7 | 0.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $27,080 | 27 | $0 (2020) |
| PFIZER INC. | $4,180 | 3 | $0 (2021) |
| Incyte Corporation | $3,461 | 8 | $0 (2022) |
| Millennium Pharmaceuticals, Inc. | $2,202 | 3 | $0 (2017) |
| COMSORT, Inc | $300.00 | 2 | $0 (2017) |
| GENZYME CORPORATION | $250.00 | 1 | $0 (2018) |
| Servier Pharmaceuticals LLC | $159.26 | 4 | $0 (2021) |
| Pharmacyclics LLC, An AbbVie Company | $108.07 | 5 | $0 (2023) |
| Merck Sharp & Dohme Corporation | $15.61 | 1 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $64.08 | 3 | Pharmacyclics LLC, An AbbVie Company ($64.08) |
| 2022 | $3,505 | 10 | Incyte Corporation ($3,461) |
| 2021 | $180.26 | 5 | Servier Pharmaceuticals LLC ($159.26) |
| 2020 | $6,216 | 3 | PFIZER INC. ($3,900) |
| 2019 | $5,787 | 9 | AstraZeneca Pharmaceuticals LP ($5,527) |
| 2018 | $5,186 | 6 | AstraZeneca Pharmaceuticals LP ($4,936) |
| 2017 | $16,819 | 19 | AstraZeneca Pharmaceuticals LP ($14,317) |
All Payment Transactions
55 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/23/2023 | Pharmacyclics LLC, An AbbVie Company | IMBRUVICA (Drug) | Food and Beverage | In-kind items and services | $21.40 | General |
| Category: ONCOLOGY | ||||||
| 05/25/2023 | Pharmacyclics LLC, An AbbVie Company | IMBRUVICA (Drug) | Food and Beverage | In-kind items and services | $22.39 | General |
| Category: ONCOLOGY | ||||||
| 04/28/2023 | Pharmacyclics LLC, An AbbVie Company | IMBRUVICA (Drug) | Food and Beverage | In-kind items and services | $20.29 | General |
| Category: ONCOLOGY | ||||||
| 06/17/2022 | Pharmacyclics LLC, an AbbVie Company | IMBRUVICA (Drug) | Food and Beverage | In-kind items and services | $15.73 | General |
| Category: ONCOLOGY | ||||||
| 04/28/2022 | Pharmacyclics LLC, an AbbVie Company | IMBRUVICA (Drug) | Food and Beverage | In-kind items and services | $28.26 | General |
| Category: ONCOLOGY | ||||||
| 02/16/2022 | Incyte Corporation | MONJUVI (Drug) | Travel and Lodging | Cash or cash equivalent | $56.00 | General |
| Category: Oncology | ||||||
| 02/16/2022 | Incyte Corporation | MONJUVI (Drug) | Travel and Lodging | Cash or cash equivalent | $48.00 | General |
| Category: Oncology | ||||||
| 02/15/2022 | Incyte Corporation | MONJUVI (Drug) | Consulting Fee | Cash or cash equivalent | $2,070.00 | General |
| Category: Oncology | ||||||
| 01/22/2022 | Incyte Corporation | MONJUVI (Drug) | Travel and Lodging | Cash or cash equivalent | $330.67 | General |
| Category: Oncology | ||||||
| 01/22/2022 | Incyte Corporation | MONJUVI (Drug) | Travel and Lodging | Cash or cash equivalent | $258.77 | General |
| Category: Oncology | ||||||
| 01/22/2022 | Incyte Corporation | MONJUVI (Drug) | Food and Beverage | Cash or cash equivalent | $59.00 | General |
| Category: Oncology | ||||||
| 01/22/2022 | Incyte Corporation | MONJUVI (Drug) | Food and Beverage | Cash or cash equivalent | $38.28 | General |
| Category: Oncology | ||||||
| 01/20/2022 | Incyte Corporation | MONJUVI (Drug) | Consulting Fee | Cash or cash equivalent | $600.00 | General |
| Category: Oncology | ||||||
| 11/17/2021 | Servier Pharmaceuticals LLC | TIBSOVO (Drug) | Education | In-kind items and services | $48.35 | General |
| Category: ONCOLOGY | ||||||
| 11/17/2021 | Servier Pharmaceuticals LLC | TIBSOVO (Drug) | Education | In-kind items and services | $48.35 | General |
| Category: ONCOLOGY | ||||||
| 11/17/2021 | Servier Pharmaceuticals LLC | TIBSOVO (Drug) | Education | In-kind items and services | $31.28 | General |
| Category: ONCOLOGY | ||||||
| 11/17/2021 | Servier Pharmaceuticals LLC | TIBSOVO (Drug) | Education | In-kind items and services | $31.28 | General |
| Category: ONCOLOGY | ||||||
| 08/27/2021 | PFIZER INC. | ORGOVYX (Drug) | Education | In-kind items and services | $21.00 | General |
| Category: ONCOLOGY | ||||||
| 11/24/2020 | AstraZeneca Pharmaceuticals LP | IMFINZI (Drug) | Consulting Fee | Cash or cash equivalent | $2,300.00 | General |
| Category: Oncology | ||||||
| 02/13/2020 | Merck Sharp & Dohme Corporation | KEYTRUDA (Biological) | Education | In-kind items and services | $15.61 | General |
| Category: ONCOLOGY | ||||||
| 01/02/2020 | PFIZER INC. | LORBRENA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,900.00 | General |
| Category: ONCOLOGY | ||||||
| 10/18/2019 | PFIZER INC. | — | Food and Beverage | In-kind items and services | $259.18 | General |
| 09/05/2019 | Clovis Oncology, Inc. | Rubraca (Drug) | Education | In-kind items and services | $0.72 | General |
| Category: Oncology | ||||||
| 03/13/2019 | AstraZeneca Pharmaceuticals LP | TAGRISSO (Drug) | Consulting Fee | Cash or cash equivalent | $4,550.00 | General |
| Category: Oncology | ||||||
| 03/08/2019 | AstraZeneca Pharmaceuticals LP | TAGRISSO (Drug) | Travel and Lodging | In-kind items and services | $291.00 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 696 | 1,342 | $283,515 | $114,934 |
| 2022 | 8 | 885 | 1,480 | $266,470 | $130,688 |
| 2021 | 10 | 993 | 1,781 | $322,358 | $163,978 |
| 2020 | 12 | 952 | 1,603 | $301,805 | $122,789 |
Total Patients
3,526
Total Services
6,206
Medicare Billing
$532,388
Procedure Codes
54
All Medicare Procedures & Services
54 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 251 | 608 | $102,197 | $45,826 | 44.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 82 | 215 | $56,428 | $24,095 | 42.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 125 | 250 | $42,132 | $18,568 | 44.1% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2023 | 39 | 39 | $17,275 | $5,473 | 31.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 31 | 48 | $12,464 | $5,174 | 41.5% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 52 | 60 | $12,346 | $3,887 | 31.5% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 24 | 24 | $10,578 | $3,327 | 31.5% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 29 | 30 | $11,864 | $3,245 | 27.3% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 11 | 11 | $6,446 | $1,584 | 24.6% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 13 | 16 | $4,784 | $1,581 | 33.0% |
| 99497 | Advance care planning, first 30 minutes | Facility | 2023 | 19 | 19 | $4,955 | $1,189 | 24.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 20 | 22 | $2,046 | $985.68 | 48.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 235 | 464 | $65,495 | $34,257 | 52.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 214 | 375 | $54,105 | $26,716 | 49.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 94 | 218 | $48,225 | $25,698 | 53.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 54 | 98 | $21,560 | $11,517 | 53.4% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 94 | 124 | $23,064 | $10,587 | 45.9% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 51 | 51 | $16,575 | $8,446 | 51.0% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2022 | 43 | 43 | $15,265 | $5,698 | 37.3% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 26 | 26 | $9,365 | $3,244 | 34.6% |
| 99497 | Advance care planning, first 30 minutes | Facility | 2022 | 19 | 22 | $5,868 | $1,428 | 24.3% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 20 | 22 | $3,102 | $1,307 | 42.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 21 | 22 | $2,046 | $1,011 | 49.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 14 | 15 | $1,800 | $777.17 | 43.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 218 | 489 | $69,225 | $36,783 | 53.1% |
About Dr. Michael Costello, MD
Dr. Michael Costello, MD is a Hematology & Oncology healthcare provider based in West Chester, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/08/2007. The National Provider Identifier (NPI) number assigned to this provider is 1366645111.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Costello, MD has received a total of $37,756 in payments from pharmaceutical and medical device companies, with $64.08 received in 2023. These payments were reported across 55 transactions from 10 companies. The most common payment nature is "Consulting Fee" ($28,845).
As a Medicare-enrolled provider, Costello has provided services to 3,526 Medicare beneficiaries, totaling 6,206 services with total Medicare billing of $532,388. Data is available for 4 years (2020–2023), covering 54 distinct procedure/service records.
Ad
Practice Information
- Specialty Hematology & Oncology
- Location West Chester, PA
- Active Since 06/08/2007
- Last Updated 02/16/2016
- Taxonomy Code 207RH0003X
- Entity Type Individual
- NPI Number 1366645111
Products in Payments
- TAGRISSO (Drug) $20,530
- LORBRENA (Drug) $3,900
- MONJUVI (Drug) $3,461
- IMFINZI (Drug) $2,300
- ALUNBRIG (Drug) $2,202
- KEYTRUDA (Biological) $315.61
- ELITEK (Drug) $250.00
- TIBSOVO (Drug) $159.26
- IMBRUVICA (Drug) $108.07
- ORGOVYX (Drug) $21.00
- Rubraca (Drug) $0.72
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hematology & Oncology Doctors in West Chester
Olugbenga Olowokure, M.d, M.D
Hematology & Oncology — Payments: $133,907
Hematology & Oncology $133,907
Dr. Rekha Chaudhary, M.d, M.D
Hematology & Oncology — Payments: $104,463
Hematology & Oncology $104,463
Molly Stumacher, Md, MD
Hematology & Oncology — Payments: $14,190
Hematology & Oncology $14,190
Cheryl Johnson, Md, MD
Hematology & Oncology — Payments: $349.94
Hematology & Oncology $349.94
Sunil Saroha, Md, MD
Hematology & Oncology — Payments: $283.94
Hematology & Oncology $283.94
Dr. Maria Vershvovsky, M.d, M.D
Hematology & Oncology — Payments: $187.09
Hematology & Oncology $187.09